Drug-Coated Balloon Angioplasty Outcomes for Vertebral Artery Stenosis, 2022-2024

A retrospective study of 121 symptomatic vertebral artery origin stenosis patients treated with drug-coated balloon angioplasty at Xuzhou First People’s Hospital between January 2022 and December 2024. The data includes stenosis rates at baseline, post-procedure, and follow-up, and was used to analyze predictors for bailout stenting. The dataset was authored by Yuerong Dong and is available under a CC-BY-4.0 license.

Use Cases

• Predicting the need for bailout stenting based on patient characteristics like blood pressure and concomitant stenosis.
• Analyzing the angiographic durability of drug-coated balloon angioplasty over short- and long-term follow-up periods.
• Developing or validating clinical nomograms for procedural planning in symptomatic vertebral artery stenosis.
• Comparing stenosis rate trajectories between patients who received balloon-only treatment versus those requiring bailout stenting.

Strengths

• Includes data from 121 consecutive patients, providing a real-world cohort.
• Reports specific statistical results, including a technical success rate of 77.6% and a C-index of 0.807 for the predictive nomogram.
• Contains longitudinal data with stenosis rates measured at baseline, immediate post-procedure, and at ≥3- and ≥12-month follow-ups.

Limitations

• Column-level documentation is absent; field semantics must be inferred after download.
• Row count is unknown, which may limit suitability assessment.
• Data is from a single-center study, which may limit generalizability.

Provenance

Source

Xuzhou First People’s Hospital

Collection Method

Single-center retrospective study.

Time Range

January 2022 to December 2024

Freshness

Last updated 2026-04-14 04:20:31; freshness should be verified.

Geography

Data likely originates from China, given the hospital location.